Fig. 7From: NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysisRNA interaction of NEAT1 with MTRNR2L8 a, hsa-miR-612 b, and XIST cBack to article page